首页 / 专利分类库 / 有机化学 / 无环或碳环化合物 / 连接在同一个碳架上的含氨基和醚化的羟基的化合物 / ·醚化的羟基和氨基连接在同一个碳架的非环碳原子上
序号 专利名 申请号 申请日 公开(公告)号 公开(公告)日 发明人
41 HYDROPHILIC POLYETHER AMINE SOLUTION AND USES THEREOF PCT/US2022027779 2022-05-05 WO2022235871A1 2022-11-10 ZHAO HAIBO
Systems Solutions and methods for cleaning the air intake valve of a GDI engine during engine operation with a PEA-water solution injection.
42 液晶表示素子及びその製造方法 PCT/JP2016/061794 2016-04-12 WO2017134841A1 2017-08-10 林 正直; 清水 健太; 楠本 哲生; 桑名 康弘

本発明は、誘電率異方性、粘度、ネマチック相上限温度、回転粘度(γ)等の液晶表示素子としての諸特性及び液晶表示素子の焼き付き特性を悪化させることなく、製造時の滴下痕が発生し難く、液晶表示素子としての諸特性が向上した、高い信頼性を有する液晶表示素子及びその製造方法を提供する。また、本発明によれば、液晶表示素子としての高速応答性優れ、焼き付きの発生が少なく、その製造時における滴下痕の発生が少なく、液晶表示素子としての諸特性に優れ、また、信頼性が高いため、液晶TV、モニター等の表示素子として有効に用いることができる。また、本発明によれば、滴下痕の発生し難い効率的な液晶表示素子の製造が可能となる。

43 SUBSTITUTED PHENETHYLAMINES PCT/US2008/065627 2008-06-03 WO2008151179A2 2008-12-11 GANT, Thomas, G.; SARSHAR, Sepehr

Disclosed herein are substituted phenethylamine alpha adrenergic receptor modulators of Formula I, process of preparation thereof, pharmaceutical compositions thereof, and methods of use thereof.

44 METHOD OF PRODUCING ALKOXYLATED ETHER AMINES AND USES THEREOF EP22881711.0 2022-10-12 EP4416129A1 2024-08-21 DELUGE, Maxence M.; LEWIS, David C.
A process for preparing alkoxylated ether amines including performing an alkoxylation reaction between a Guerbet alcohol and an epoxide in the presence of a catalyst to obtain an alkoxylated alcohol. Performing an amination reaction on the alkoxylated alcohol in the presence of ammonia and hydrogen to form an alkoxylated Guerbet amine.
45 HYDROPHILIC POLYETHER AMINE SOLUTION AND USES THEREOF EP22799554.5 2022-05-05 EP4334374A1 2024-03-13 ZHAO, Haibo
System Solutions and methods for cleaning the air intake valve of a GDI engine during engine operation with a PEA-water solution injection.
46 SURFACTANT COMPOUNDS AND AGROCHEMICAL COMPOSITIONS EP04736668.7 2004-06-11 EP1643834B1 2007-08-01 BEVINAKATTI, Hanamanthsa Shankarsa
Compounds of the formula: Rl R2N-CH2-CHO[(AO)m1 R4]-CH2-OR3 where Rl is alkoxylated polyhydroxy hydrocarbyl; R2 is as defined for Rl, or hydrocarbyl, particularly alkyl or alkoxyalkyl, alkoxylated hydroxyalkyl, or a group: -CH2-CHO[(AO)ml R4]-CH2-OR3; R3 is hydrocarbyl; AO is alkyleneoxy; ml is from 0 to 50; such that the average total number of alkyleneoxy groups in the molecule is from 3 to 50; and R4 is hydrogen, or alkyl, are useful as agrochemical adjuvants. The agrochemical can be a plant growth regulator, herbicide, and/or pesticide, for example insecticide, fungicide, acaricide, nematocide, miticide, rodenticide, bactericide, molluscicide and/or bird repellent. Particularly useful formulations include water soluble herbicide(s), particularly such as glyphosate, glufosinate and paraquat.
47 Anti-inflammatory agents EP88300163.8 1988-01-11 EP0276065A1 1988-07-27 Bollinger, Nancy Grace; Goodson, Theodore, Jr.; Herron, David Kent

This invention provides benzene derivatives of the Formula I pharmaceutical formulations of those derivatives, and a method of using the derivatives for the treatment of inflammation in mammals.

48 METHOD OF PRODUCING ALKOXYLATED ETHER AMINES AND USES THEREOF PCT/US2022046413 2022-10-12 WO2023064364A1 2023-04-20 DELUGE MAXENCE M; LEWIS DAVID C
A process for preparing alkoxylated ether amines including performing an alkoxylation reaction between a Guerbet alcohol and an epoxide in the presence of a catalyst to obtain an alkoxylated alcohol. Performing an amination reaction on the alkoxylated alcohol in the presence of ammonia and hydrogen to form an alkoxylated Guerbet amine.
49 AMINO-COMBRETASTATIN DERIVATIVE AND USE THEREOF PCT/CN2021128275 2021-11-02 WO2022100487A1 2022-05-19 WANG JIANPING
Disclosed is an amino-combretastatin derivative, and in particular a compound represented by general formula (I), a pharmaceutically acceptable salt thereof, a hydrate thereof, or a hydrate of the pharmaceutically acceptable salt thereof, a solvate thereof or a solvate of the pharmaceutically acceptable salt thereof, and an isomer thereof. In general formula (I), R1 is selected from a C1-C3 alkyl or a C1-C3 haloalkyl, and R2 and R3 are respectively and independently selected from a C1-C6 alkyl, a C1-C6 haloalkyl or a C1-C6 alcohol group. The present invention also relates to the use of such compounds in the preparation of drugs for the treatment of diseases caused by abnormal neovascularization, and tubulin aggregation inhibitors.
50 SUBSTITUTED PHENETHYLAMINES PCT/US2008065627 2008-06-03 WO2008151179A3 2009-03-26 GANT THOMAS G; SARSHAR SEPEHR
Disclosed herein are substituted phenethylamine alpha adrenergic receptor modulators of Formula I, process of preparation thereof, pharmaceutical compositions thereof, and methods of use thereof.
51 HIGH PURITY (1R,2S,4R)-(-)-2-[(2'-{N,N-DIMETHYLAMINO}-ETHOXY)]-2-[PHENYL]-1,7,7-TRI-[METHYL]-BICYCLO[2.2.1]HEPTANE AND PHARMACEUTICALLY ACCEPTABLE ACID ADDITION SALTS THEREOF, PROCESS FOR THE PREPARATION OF THESE COMPOUNDS AND MEDICAMENTS CONTAINING THEM PCT/HU0000044 2000-05-10 WO0068183A3 2001-07-26 LUKACS GYULA; SIMIG GYULA; MEZEI TIBOR; BUDAI ZOLTAN; PORCS-MAKKAY MARTA; KRASZNAI GYOERGY; NAGY KALMAN; VERECZKEYNE DONATH GYOERGYI; SZABO TIBOR; NEMETH NORBERT; SZULAGYI JANOS
The invention relates to high purity (1R,2S,4R)-(-)-2- [(2'-{N,N- dimethylamino} -ethoxy)] -2-[phenyl] -1,7,7-tri-[methyl] -bicyclo[2.2.1] heptane and pharmaceutically acceptable acid addition salts thereof containing not more than 0.2 % of (1R,3S,4R)-3- [(2'-{N,N- dimethylamino} -ethyl)]-1,7,7-tri- [methyl] -bicyclo [2.2.1] heptane-2-one and/or of a pharmaceutically acceptable acid addition salt thereof. Furthermore the invention is concerned with a process for the preparation of these compounds. Moreover the invention relates to medicaments containing 1 or more of these compounds and their use.
52 폴리아민 화합물의 제조 방법 및 그의 응용 KR1020217027248 2021-02-05 KR1020210111322A 2021-09-10
53 비수 용매 내 4차 암모늄 히드록사이드의 색 억제제 KR1020157019935 2014-01-10 KR101727555B1 2017-04-17 엥겔,팀; 반리에,알프레드
비수용매내 4차오늄히드록사이드; 및이미다졸리딘-2,4-디온을포함하고, 4차암모늄히드록사이드는조성물의약 5중량% 내지약 50중량%의농도를가지며, 이미다졸리딘-2,4-디온은조성물의약 10 내지약 5000 백만분율의농도를가지는, 조성물.
54 비수 용매 내 4차 암모늄 히드록사이드의 색 억제제 KR1020157019935 2014-01-10 KR1020150103083A 2015-09-09 엥겔,팀; 반리에,알프레드
비수 용매 내 4차 오늄 히드록사이드; 및 이미다졸리딘-2,4-디온을 포함하고, 4차 암모늄 히드록사이드는 조성물의 약 5중량% 내지 약 50중량%의 농도를 가지며, 이미다졸리딘-2,4-디온은 조성물의 약 10 내지 약 5000 백만분율의 농도를 가지는, 조성물.
55 LUBRICATING OIL ADDITIVE, LUBRICATING OIL ADDITIVE COMPOSITION, AND LUBRICATING OIL COMPOSITION CONTAINING THESE EP20769802.8 2020-03-10 EP3940045B1 2024-12-25 ODA, Kazuhiro; SHIMIZU, Yutaro; KAWAMOTO, Hideki
A lubricant additive includes a monoester carboxylic acid salt (A) represented by formula (1).In formula (1), R1 represents a single bond between carbon atoms of carbonyl groups, or a divalent hydrocarbon group having 1 to 4 carbon atoms, and R2 represents a hydrocarbon group having 1 to 22 carbon atoms. AO represents an oxyalkylene group of one type selected from oxyalkylene groups having 2 to 4 carbon atoms, or a mixed oxyalkylene group of two or more types selected from oxyalkylene groups having 2 to 4 carbon atoms, and n is an average number of added moles of the oxyalkylene group represented by AO and is 0 to 5. M represents organic ammonium.
56 AMINO-COMBRETASTATIN DERIVATIVE AND USE THEREOF EP21891014.9 2021-11-02 EP4245750A1 2023-09-20 WANG, Jianping

Disclosed is an amino-combretastatin derivative, and in particular a compound represented by general formula (I), a pharmaceutically acceptable salt thereof, a hydrate thereof, or a hydrate of the pharmaceutically acceptable salt thereof, a solvate thereof or a solvate of the pharmaceutically acceptable salt thereof, and an isomer thereof. In general formula (I), R1 is selected from a C1-C3 alkyl or a C1-C3 haloalkyl, and R2 and R3 are respectively and independently selected from a C1-C6 alkyl, a C1-C6 haloalkyl or a C1-C6 alcohol group. The present invention also relates to the use of such compounds in the preparation of drugs for the treatment of diseases caused by abnormal neovascularization, and tubulin aggregation inhibitors.

57 LUBRICATING OIL ADDITIVE, LUBRICATING OIL ADDITIVE COMPOSITION, AND LUBRICATING OIL COMPOSITION CONTAINING THESE EP20769802.8 2020-03-10 EP3940045A4 2022-12-14 ODA, Kazuhiro; SHIMIZU, Yutaro; KAWAMOTO, Hideki
A lubricant additive includes a monoester carboxylic acid salt (A) represented by formula (1).In formula (1), R1 represents a single bond between carbon atoms of carbonyl groups, or a divalent hydrocarbon group having 1 to 4 carbon atoms, and R2 represents a hydrocarbon group having 1 to 22 carbon atoms. AO represents an oxyalkylene group of one type selected from oxyalkylene groups having 2 to 4 carbon atoms, or a mixed oxyalkylene group of two or more types selected from oxyalkylene groups having 2 to 4 carbon atoms, and n is an average number of added moles of the oxyalkylene group represented by AO and is 0 to 5. M represents organic ammonium.
58 SURFACTANT COMPOUNDS AND AGROCHEMICAL COMPOSITIONS EP04736668.7 2004-06-11 EP1643834A1 2006-04-12 BEVINAKATTI, Hanamanthsa Shankarsa
Compounds of the formula: Rl R2N-CH2-CHO[(AO)m1 R4]-CH2-OR3 where Rl is alkoxylated polyhydroxy hydrocarbyl; R2 is as defined for Rl, or hydrocarbyl, particularly alkyl or alkoxyalkyl, alkoxylated hydroxyalkyl, or a group: -CH2-CHO[(AO)ml R4]-CH2-OR3; R3 is hydrocarbyl; AO is alkyleneoxy; ml is from 0 to 50; such that the average total number of alkyleneoxy groups in the molecule is from 3 to 50; and R4 is hydrogen, or alkyl, are useful as agrochemical adjuvants. The agrochemical can be a plant growth regulator, herbicide, and/or pesticide, for example insecticide, fungicide, acaricide, nematocide, miticide, rodenticide, bactericide, molluscicide and/or bird repellent. Particularly useful formulations include water soluble herbicide(s), particularly such as glyphosate, glufosinate and paraquat.
59 Process for preparing (1R, 2S, 4R)-(-)-2-[(2'-(N,N-dimethylamino)-ethoxy)]-2-[phenyl]-1,7,7-tri-[methyl]-bicyclo[2.2.1]heptane and pharmaceutically acceptable acid addition salts thereof EP00110122.9 2000-05-10 EP1052243A2 2000-11-15 Lukacs, Gyula; Simig, Gyula; Mezei, Tibor; Budai, Zoltan; Porcs-Makkay, Marta; Krasznai, Gyorgy; Nagy, Kalman; Vereczkey, Gyorgyi Donath; Szabo, Tibor; Nemeth, Norbert; Szulagyi, Janos

The invention relates to a process for preparing (1R,2S,4R)-(-)-2-[(2'-{N,N-dimethylamino}-ethoxy)]-2--[phenyl]-1,7,7-tri-[methyl]-bicyclo[2.2.1]heptane and pharmaceutically acceptable acid addition salts thereof with higher yields and higher grades of purity.

60 Process for manufacture of N-(polyoxyalkyl)-N-(alkyl)amines EP89105623.6 1989-03-30 EP0335393A1 1989-10-04 Gerkin, Richard Michael; Cowherd, Frank Garnett; Schreck, David James; Kirchner, David Lee

A process for the manufacture of N-(polyoxyalkyl)-N-(alkyl)amines is provided by reacting an alcohol with a secondary amine.

QQ群二维码
意见反馈